Plant-predominant eating in stage 3b CKD with type 2 diabetes
Ms. R is a 62-year-old woman with a 12-year history of type 2 diabetes and stage 3b chronic kidney disease (eGFR 38 mL/min/1.73 m², urine albumin-to-creatinine ratio 350 mg/g). Her medications are metformin 1,000 mg twice daily, empagliflozin 10 mg daily, lisinopril 20 mg daily, and atorvastatin 40 mg daily. Her HbA1c is 8.4%, blood pressure 132/78 mm Hg, BMI 31 kg/m², potassium 4.9 mmol/L, bicarbonate 21 mmol/L, and hemoglobin 10.8 g/dL. She currently eats chicken or fish five evenings a week, white rice, and few vegetables. After watching a documentary, she wants to start a whole-food, plant-predominant diet. She has read that plant diets cause protein deficiency and dangerously high potassium, and she asks whether she can stop her diabetes and blood pressure medicines once she changes her diet. She is motivated but anxious and wants a specific plan.
1. How would you counsel Ms. R about protein and potassium adequacy on a whole-food, plant-predominant diet with CKD stage 3b? Include specific foods and monitoring.
Read the worked answer
Start by correcting the two fears rather than debating the documentary. In CKD stage 3b, a whole-food plant-predominant diet can be appropriate, but it must be planned. Aim for adequate energy and total protein near 0.8 g/kg/day (about 55–60 g for her ideal body weight), not a high-protein diet. Plant proteins-lentils, beans, tofu, soy, whole grains-are acceptable; there is no requirement for animal protein. Potassium does not need blanket restriction. Review her potassium 4.9 and bicarbonate 21: encourage fruits and vegetables but choose lower-potassium choices if needed, avoid salt substitutes containing potassium chloride, and do not restrict all high-potassium foods reflexively. Monitor potassium and bicarbonate after 2–4 weeks. Include legumes gradually if bloating occurs. Refer to a renal dietitian for a culturally acceptable plan. Emphasize vitamin B12 from fortified foods or a supplement, vitamin D, and iron with vitamin C. Avoid excessive processed plant foods and coconut oil.
2. Which of her medications need review, and what follow-up would you arrange in the next 4–8 weeks?
Read the worked answer
Metformin: at eGFR 38, continuing is possible but the dose should generally not exceed 1,000 mg/day; reduce from 2,000 mg to 500–1,000 mg/day and monitor eGFR, B12, and GI tolerance. Do not stop empagliflozin-SGLT2 inhibitors slow CKD progression and reduce heart failure risk; continue unless she develops volume depletion, genital mycotic infection, or euglycemic DKA. Lisinopril should continue for albuminuria; after a major dietary change, check potassium and creatinine in 1–2 weeks and again at 4–8 weeks. Atorvastatin continues. Arrange a home BP log, HbA1c in 3 months, basic metabolic panel in 1–2 weeks, and urine albumin-to-creatinine ratio in 3–6 months. Educate about sick-day rules for metformin and empagliflozin. Coordinate with nephrology if eGFR falls by more than 30% or potassium rises.
3. How do you respond to her question about stopping medications, and what is the appropriate role of diet in her diabetes and hypertension management?
Read the worked answer
Tell her clearly: diet is a powerful adjunct, not a replacement, and no medication should be stopped on day one. Her HbA1c of 8.4% and albuminuria mean she is at high risk; stopping lisinopril could worsen albuminuria, and stopping empagliflozin would remove renal and cardiovascular protection. The realistic goal is improvement, possible partial remission, and deprescribing only after sustained glucose and BP control with monitoring. Set a 3-month trial: a whole-food plate with 50% non-starchy vegetables, 25% legumes, 25% whole grains, plus fruit and nuts/seeds; limit refined starches and salt. Review glucose logs; metformin may need adjustment for CKD. If HbA1c falls below 6.5% and BP remains below 130/80 consistently, revisit doses with her. Document shared decision-making and schedule close follow-up.